Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo
about
Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry.Database of T cell-defined human tumor antigens: the 2013 updatePhosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed selfPhosphorylated self-peptides alter human leukocyte antigen class I-restricted antigen presentation and generate tumor-specific epitopesStructural basis for the presentation of tumor-associated MHC class II-restricted phosphopeptides to CD4+ T cellsPhosphoproteome analysis of capacitated human sperm. Evidence of tyrosine phosphorylation of a kinase-anchoring protein 3 and valosin-containing protein/p97 during capacitationImmunoproteomics: Mass spectrometry-based methods to study the targets of the immune responseLoss of CD4 T-cell-dependent tolerance to proteins with modified amino acidsInflammation-associated nitrotyrosination affects TCR recognition through reduced stability and alteration of the molecular surface of the MHC complexIdentification and characterization of AGS4: a protein containing three G-protein regulatory motifs that regulate the activation state of GialphaThe antigenic identity of human class I MHC phosphopeptides is critically dependent upon phosphorylation status.Complementary IMAC enrichment methods for HLA-associated phosphopeptide identification by mass spectrometry.MHC-restricted phosphopeptides from insulin receptor substrate-2 and CDC25b offer broad-based immunotherapeutic agents for cancer.Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites.MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia.PICquant: a quantitative platform to measure differential peptide abundance using dual-isotopic labeling with 12C6- and 13C6-phenyl isocyanatePhosphorylation of fanconi anemia (FA) complementation group G protein, FANCG, at serine 7 is important for function of the FA pathway.Strategies and challenges in eliciting immunity to melanoma.Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapyIdentification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy.Mass spectrometric identification of phosphorylation sites of rRNA transcription factor upstream binding factor.The contributions of mass spectrometry to understanding of immune recognition by T lymphocytes.Factors governing the solubilization of phosphopeptides retained on ferric NTA IMAC beads and their analysis by MALDI TOFMS.Proteomics in cancer vaccine development.Comparative quantitative mass spectrometry analysis of MHC class II-associated peptides reveals a role of GILT in formation of self-peptide repertoireActivated antigen-presenting cells select and present chemically modified peptides recognized by unique CD4 T cells.An antigenic peptide produced by reverse splicing and double asparagine deamidationComprehensive and reproducible phosphopeptide enrichment using iron immobilized metal ion affinity chromatography (Fe-IMAC) columns.Tumors reveal their secrets to cytotoxic T cells.Tumor antigens and proteomics from the point of view of the major histocompatibility complex peptides.MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cellsIdentities of P2 and P3 Residues of H-2Kb-Bound Peptides Determine Mouse Ly49C Recognition.Charting Immune Signaling Proteomes En Route to New Therapeutic Strategies.MHC-bound antigens and proteomics for novel target discovery.Use of proteomics to define targets of T-cell immunity.The seven dirty little secrets of major histocompatibility complex class I antigen processing.Quantitative phosphoproteomic analysis of T cell receptor signaling in diabetes prone and resistant miceImpact of glycans on T-cell tolerance to glycosylated self-antigens.Increased diversity of the HLA-B40 ligandome by the presentation of peptides phosphorylated at their main anchor residueQuantitative analysis of phosphorylation-based protein signaling networks in the immune system by mass spectrometry.
P2860
Q24541325-52FC71C1-E770-4F34-A90D-D224756700E0Q27022422-57FF3EE3-F54E-4978-A833-7BBE171512E7Q27652421-181A9002-6998-4AE8-947C-34BE5D759352Q27653670-0D97E8F5-C8EA-4B1B-8E6E-8B580E8E3216Q27660843-C184E220-0E5F-4215-A867-60FC251C8772Q28201277-A0ACA3AA-E046-43D3-98E4-F3ADDA90E0DBQ28238379-32EBA1BC-7F77-4AB9-B8FE-659E80BDA746Q28243525-42BE3C7C-70C5-4D26-A81E-93702C3EF5B5Q28481493-73656475-A0AD-4713-95E9-82DC3B2D327FQ28572549-1258AC9E-09A9-4D71-A2F1-8DCE82C94304Q30252521-49BD0F71-9A7A-42CE-A7BD-6ECC7BA14A41Q30278896-AE35414E-346F-4020-9440-431CDEBD8F00Q30303138-B6008F42-3439-471F-A3B1-AEC87CCB3087Q30309352-9A2ED593-2BB8-4717-A3C2-C34ABD2398FDQ30412320-3D6D7BB8-6F06-4E60-8BF4-C34ECE39F4C9Q30428469-120052EE-97FB-4A7B-8225-3F832709B57DQ30434133-EEDB74B5-373A-4899-8717-8232570DFCFDQ30435893-C2D34A54-FBB5-41FF-848A-F3E86E529A24Q30437344-1AFC926F-DBF8-4E9E-A502-0BE3BA489A9AQ30441689-705520B8-DD8F-43D0-B2BB-78CF5495DDCAQ30442406-4633D0A0-346F-49BC-B7E4-BC1B6990607CQ30444065-40096A8E-6B99-4D8B-9868-033A80D3A192Q30855809-8B9D0BCA-8C8E-40F5-9405-FA2038ACEFB9Q33215044-2FC9D8F4-8979-48FE-AEA1-31EBD526D191Q33582318-099F605C-CDAC-451E-9EB1-BAA5CDC34B81Q33824207-B28AAAE2-96A2-42ED-9047-FF04586E83E8Q34192290-3297B993-3994-4622-AD74-8EEEA7F21DB4Q34884182-406806AF-D12D-456C-B15D-25B507004BFDQ35075389-C3FA881F-580C-4654-87AB-0EFD03EDF287Q35160569-855757ED-6C39-406D-8949-AE74287A2176Q35573814-C7B96DC0-352D-4BC9-98D1-7B354C8A0465Q35683920-A5035605-C805-4156-B227-7AB54A521BF8Q35815990-F09107F5-13D3-4BAF-BEF6-60BB2685D90AQ35911151-A14822FE-6896-4E78-B525-F479EA0F4426Q36184807-BCBD2AD6-87C7-4222-A267-D7E2790A8371Q36266421-BEE5A848-CE32-4D2D-91E0-D2D65155ED6AQ36700960-A7F47AB2-452E-41CB-9393-D69FE5563CB7Q37216317-B2947024-58E5-442F-8E3F-FB16AD2F1D8CQ37563889-33728F18-A83E-4156-A40B-C7F81126C64EQ37788070-05A3985E-2CA6-4D63-AD40-8AA7E57914B6
P2860
Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Phosphorylated peptides are na ...... plex class I molecules in vivo
@ast
Phosphorylated peptides are na ...... plex class I molecules in vivo
@en
type
label
Phosphorylated peptides are na ...... plex class I molecules in vivo
@ast
Phosphorylated peptides are na ...... plex class I molecules in vivo
@en
prefLabel
Phosphorylated peptides are na ...... plex class I molecules in vivo
@ast
Phosphorylated peptides are na ...... plex class I molecules in vivo
@en
P2093
P2860
P356
P1476
Phosphorylated peptides are na ...... plex class I molecules in vivo
@en
P2093
A L Zarling
J Shabanowitz
S B Ficarro
P2860
P304
P356
10.1084/JEM.192.12.1755
P407
P577
2000-12-01T00:00:00Z